Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines
- 30 September 1993
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 14 (9) , 325-331
- https://doi.org/10.1016/0165-6147(93)90005-5
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The NMDA Receptor, NMDA Antagonists and Epilepsy TherapyDrugs, 1992
- A novel specific binding site for anxiolytic homophthalazines in the rat brainFEBS Letters, 1992
- Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat.Stroke, 1992
- Neurotoxin‐Related Research: From the Laboratory to the ClinicAnnals of the New York Academy of Sciences, 1992
- Anticonvulsant 1-Phenylcycloalkylamines: Two Analogues with Low Motor Toxicity When Orally AdministeredEpilepsia, 1992
- GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneuronesNeuroscience Letters, 1991
- Spider toxins as tools for dissecting elements of excitatory amino acid transmissionTrends in Neurosciences, 1988
- Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemiaNeuroscience Letters, 1988
- Memantine (1-amino-3,5-dimethyladamantane) blocks the serotonin-induced depolarization response in a neuronal cell lineBrain Research, 1988
- Is tofisopam an atypical anxiolytic?Neuroscience & Biobehavioral Reviews, 1986